An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Mohamed Zakarea Wfa, Tanta, Egypt
Hospital Armand Trousseau, APHP Service : Department of Neonatology, Paris, France
Tanta University, Tanta, El-Gharbia, Egypt
Fayoum University Hospital, Fayoum, Faiyum, Egypt
Menoufia university hospital, Shibin Elkom, Egypt
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Ain Shams University, Cairo, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.